| 1 |
Morgan, D. O. 1995. Principles of CDK regulation. Nature 374, 131-134.
DOI
|
| 2 |
Ogunleye, A. A., Xue, F. and Michels, K. B. 2010. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 119, 477-484.
DOI
|
| 3 |
Rey, M., Fernandez, P. L., Jares, P., Rey, M. J., Fernandez, P. L., Jares, P., Munoz, M., Nadal, A., Peiro, N., Nayach, I., Mallofre, C., Muntane, J., Campo, E., Estape, J. and Cardesa, A. 1998. P21WAF1/CIP1 is associated with cyclin D1 CCND1 expression and tubular differentiation but is independent of p53 overexpression in human breast carcinoma. J. Pathol. 184, 265-271.
DOI
|
| 4 |
Salnikow, K., Costa, M., Figg, W. D. and Blagosklonny, M. V. 2000. Hyperinducibility of hypoxia-responsive genes without p53/p21-dependent checkpoint in aggressive prostate cancer. Cancer Res. 60, 5630-5634.
|
| 5 |
Schwartz, D. and Rotter, V. 1998. P53-dependent cell cycle control: response to genotoxic stress. Semin. Cancer Biol. 8, 325-336.
DOI
|
| 6 |
Shirakami, Y., Shimizu, M. and Moriwaki, H. 2012. Cancer chemoprevention with green tea catechins: from bench to bed. Curr. Drug Targets. 13, 1842-1857.
DOI
|
| 7 |
Wakasugi, E., Kobayashi, T., Tanaki, Y., Ito, Y., Miyashiro, I., Komoike, Y., Takeda, T., Shin, E., Takatsuka, Y., Kikkawa, N., Monden, T. and Monden, M. 1997. p21 and p53 protein expression in breast cancer. Am. J. Clin. Pathol. 107, 684-691.
DOI
|
| 8 |
May, P. and May, E. 1999. Twenty years of p53 research: structural and functional aspects of the p53 protein. Oncogene 18, 7621-7636.
DOI
|
| 9 |
Butt, M. S. and Sultan, M. T. 2009. Green tea: nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 49, 463-473.
DOI
|
| 10 |
Bettuzzi, S., Brausi, M., Rizzi, F., Castagnetti, G., Peracchia, G. and Corti, A. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high grade prostate intraepithelial neoplasia. Cancer Res. 66, 1234-1240.
DOI
|
| 11 |
Fung, T. K. and Poon, R. Y. 2005. A roller coaster ride with the mitotic cyclins. Semin. Cell Dev. Biol. 16, 335-342.
DOI
|
| 12 |
Caffo, O., Doglioni, C., Veronese, S., Bonzanini, M., Marchetti, A., Buttitta, F., Fina, P., Leek, R., Morelli, L., Palma, P. D., Harris, A. L. and Barbareschi, M. 1996. Prognostic value of p21WAF1 and p53 expression in breast carcinoma: An immuno-histochemical study in 261 patients with long term follow-up. Clin. Cancer Res. 2, 1591-1599.
|
| 13 |
Chen, Q. M., Bartholomew, J. C., Campisi, J., Acosta, M., Reagan, J. D. and Ames, B. N. 1998. Molecular analysis of H2O2-induced senescent-like growth arrest in normal human fibroblasts: p53 and Rb control G1 arrest but not cell replication. Biochem. J. 332, 43-50.
DOI
|
| 14 |
Clement, Y. 2009. Can green tea do that? A literature review of the clinical evidence. Prev. Med. 49, 83-87.
DOI
|
| 15 |
Henning, S. M., Wang, P., Carpenter, C. L. and Heber, D. 2013. Epigenetic effects of green tea polyphenols in cancer. Epigenomics 5, 729-741.
DOI
|
| 16 |
Khan, N., Afaq, F., Saleem, M., Ahmad, N. and Mukhtar, H. 2006. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 66, 2500-2505.
DOI
|
| 17 |
Iwasaki, M., Inoue, M., Sasazuki, S., Sawada, N., Yamaji, T., Shimazu, T., Willett, W. C. and Tsugane, S. 2010. Green tea drinking and subsequent risk of breast cancer in a population-based cohort of Japanese women. Breast Cancer Res. 12, R88.
DOI
|
| 18 |
Kim, Z., Min, S. Y., Yoon, C. S., Jung, K. W., Ko, B. S., Kang, E., Nam, S. J., Lee, S. and Hur, M. H. 2015. The basic facts of Korean breast cancer in 2012: Results from a nationwide survey and breast cancer registry database. J. Breast Cancer 18, 103-111.
DOI
|
| 19 |
Kern, S. E., Kinzler, K. W., Bruskin, A., Jarosz, D., Friedman, P., Prives, C. and Vogelstein, B. 1991. Identification of p53 as a sequence-specific DNA-binding protein. Science 252, 1708-1711.
DOI
|
webmaster
